Capsaicin

Allopathic
Indications
  • Neuropathic Pain:
    Used for symptomatic relief of neuropathic pain, including postherpetic neuralgia and diabetic peripheral neuropathy.
  • Osteoarthritis Pain:
    Indicated for relief of mild to moderate localized pain associated with osteoarthritis.
  • Musculoskeletal Pain:
    Used for temporary relief of minor aches and pains of muscles and joints due to strains, sprains, and arthritis.
  • Psoriasis:
    Topical capsaicin may be used off-label for symptomatic relief of pruritus and pain in psoriasis.
  • Other Off-label Uses:
    Management of chronic pruritus and cluster headaches (nasal formulation).
Dosage & Administration
  • Topical Creams/Ointments (0.025% to 0.1%):
    Apply thinly to affected area 3 to 4 times daily. Wash hands thoroughly after application.
  • Patch (8%):
    For postherpetic neuralgia, a single application of an 8% capsaicin patch for 30 to 60 minutes under medical supervision. May be repeated every 3 months or as needed.
  • Nasal Spray:
    Used for cluster headache; dose varies, typically 0.1% solution, administered into each nostril as directed.
  • Precautions:
    Avoid contact with eyes and mucous membranes. Do not apply to broken or irritated skin.
  • Pediatrics:
    Safety not established; use generally not recommended.
  • Elderly:
    Use caution due to potential skin sensitivity.
Mechanism of Action (MOA)

Capsaicin is a naturally occurring alkaloid derived from chili peppers that selectively binds to the transient receptor potential vanilloid 1 (TRPV1) receptor on nociceptive nerve fibers. This binding initially causes depolarization and release of substance P, a neuropeptide involved in pain transmission. Repeated or prolonged exposure depletes substance P and desensitizes sensory neurons, leading to decreased pain signaling and analgesia in the treated area.

Pharmacokinetics
  • Absorption:
    Minimal systemic absorption through intact skin; systemic bioavailability is negligible with topical use.
  • Distribution:
    Primarily localized effect at application site.
  • Metabolism:
    Metabolized hepatically after systemic absorption (very limited).
  • Elimination:
    Primarily renal excretion of metabolites.
  • Onset of Action:
    Initial burning sensation within minutes; analgesic effect develops over days to weeks with repeated use.
  • Duration:
    Analgesic effects can persist for weeks after discontinuation due to nerve desensitization.
Pregnancy Category & Lactation
  • Pregnancy:
    No well-controlled studies in pregnant women; topical use generally considered low risk due to minimal systemic absorption but should be used only if clearly needed.
  • Lactation:
    Unknown if excreted in breast milk; caution advised. Avoid application on large areas during breastfeeding.
Therapeutic Class
  • Primary: Analgesic
  • Subclass: Topical sensory neuron desensitizer
Contraindications
  • Known hypersensitivity to capsaicin or formulation excipients.
  • Open wounds, broken, or inflamed skin at application site.
  • Use contraindicated in patients with severe skin conditions in the treatment area.
Warnings & Precautions
  • Avoid contact with eyes, mucous membranes, and sensitive areas.
  • Initial burning or stinging sensation common; usually diminishes with continued use.
  • Use with caution in patients with dermatologic conditions.
  • Monitor for allergic reactions or severe skin irritation.
  • Not for systemic pain or deep tissue pain.
  • Keep out of reach of children.
Side Effects

Common:

  • Local burning, stinging, or itching sensation at application site
  • Erythema and mild skin irritation
  • Dryness or peeling of skin

Rare/Serious:

  • Severe dermatitis or allergic contact dermatitis
  • Urticaria
  • Respiratory irritation with nasal formulations
Drug Interactions
  • Minimal systemic absorption reduces interaction potential.
  • Concomitant use with other topical irritants may increase skin irritation.
  • Avoid simultaneous use with topical anesthetics at the same site.
Recent Updates or Guidelines
  • Recent clinical guidelines endorse capsaicin 8% patches as an effective option for localized neuropathic pain after failure of first-line treatments.
  • Updated safety recommendations emphasize careful application and avoidance of mucous membranes.
  • New formulations and delivery methods under investigation for improved tolerability.
Storage Conditions
  • Store at controlled room temperature, 20°C to 25°C (68°F to 77°F).
  • Protect from light and moisture.
  • Keep container tightly closed.
  • Keep out of reach of children.